Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Annals of Surgical Oncology
Erschienen in: Annals of Surgical Oncology 1/2021

02.11.2020 | Gastrointestinal Oncology

Quality-of-Life Assessment in Patients Receiving Palliative Chemotherapy: Call for Action

verfasst von: Maheswari Senthil, MD, FACS

Erschienen in: Annals of Surgical Oncology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Management of advanced, unresectable gastrointestinal cancers with palliative chemotherapy (PC) is a common and widely accepted oncologic practice as it is associated with modest survival benefit.1‐3 In addition to survival gain, the key objectives of PC should also be to improve symptoms and preserve quality of life (QOL). In a shared decision-making model, data regarding the impact of PC on symptom improvement and maintenance of QOL will greatly influence patients’ decision regarding PC. Furthermore, knowledge about disease-specific evolution of symptoms during the course of PC will improve the ability to anticipate problems, avert emergency room visits, and avoid deterioration of QOL. …
Literatur
1.
Wagner AD, Syn NL, Moehler M, et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2017;8:CD004064.PubMed
2.
Janmaat VT, Steyerberg EW, van der Gaast A, et al. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. Cochrane Database Syst Rev. 2017;11:CD004063.PubMed
3.
de Savornin Lohman E, de Bitter T, Verhoeven R, et al. Trends in treatment and survival of gallbladder cancer in the Netherlands; identifying gaps and opportunities from a nation-wide cohort. Cancers (Basel). 2020;12(4):918.CrossRef
4.
5.
Kim JW, Kim JG, Kang BW, et al. Treatment patterns and changes in quality of life during first-line palliative chemotherapy in Korean patients with advanced gastric cancer. Cancer Res Treat. 2019;51(1):223–39.CrossRef
6.
Rha SY, Lee J. Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life. Support Care Cancer. 2017;25(5):1519–27.CrossRef
7.
Tsuboi R, Sugishita M, Hirakawa Y, Ando Y. Experiences and hidden needs of older patients, their families and their physicians in palliative chemotherapy decision-making: a qualitative study. Jpn J Clin Oncol. 2020;50(7):779–86.CrossRef
8.
Potgieter T, Maree JE. The palliative chemotherapy decision and experiences of South African patients and their families. Int J Palliat Nurs. 2018;24(6):272–80.CrossRef
9.
Altemus M, Sarvaiya N, Neill Epperson C. Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol. 2014;35(3):320–30.CrossRef
10.
American Psychological Association. APA guidelines for psychological practice with boys and men. Washington, DC: American Psychological Association; 2018.
11.
Fujitani K, Yang HK, Mizusawa J, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol. 2016;17(3):309–18.CrossRef
12.
Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687–97.CrossRef
13.
Al-Batran SE, Homann N, Pauligk C, et al. Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial. JAMA Oncol. 2017;3(9):1237–44.CrossRef
14.
Fassbender K, Watanabe SM. Early palliative care and its translation into oncology practice in Canada: barriers and challenges. Ann Palliat Med. 2015;4(3):135–49.PubMed
Metadaten
Titel
Quality-of-Life Assessment in Patients Receiving Palliative Chemotherapy: Call for Action
verfasst von
Maheswari Senthil, MD, FACS
Publikationsdatum
02.11.2020
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 1/2021
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-09297-6

Weitere Artikel der Ausgabe 1/2021

Annals of Surgical Oncology 1/2021 Zur Ausgabe

Endocrine Tumors

Implications of Conversion during Attempted Minimally Invasive Adrenalectomy for Adrenocortical Carcinoma

Thoracic Oncology

Transthoracic Versus Transhiatal Esophagectomy for Esophageal Cancer: A Nationwide Propensity Score-Matched Cohort Analysis

ASO Author Reflections

ASO Author Reflections: Discussing the Oncological Feasibility of Performing Pure Laparoscopic Radical Nephroureterectomy for Upper-Tract Urothelial Carcinoma Patients: Results from a Multi-institution Collaborative Study Adjusted by Propensity Score Matching

Breast Oncology

Genetic Testing for Breast Cancer Patients: Is Everyone Who Needs a Test Getting a Test?

ASO Visual Abstract

Defining and Predicting Early Recurrence After Resection for Gallbladder Cancer

Sarcoma

Evaluating the Impact of Surveillance Follow-Up Intervals in Patients Following Resection of Primary Well-Differentiated Liposarcoma of the Retroperitoneum

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen